Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dimitra Vardalaki, M.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Dimitra Vardalaki's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Dimitra Vardalaki has written about over time.
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, 1 publications between 2022 and 2022, average publication date February 2022. Cerebral Cortex, 1 publications between 2022 and 2022, average publication date February 2022. Receptors, AMPA, 1 publications between 2022 and 2022, average publication date February 2022. Mammals, 1 publications between 2022 and 2022, average publication date November 2022. Animals, 3 publications between 2022 and 2024, average publication date March 2023. Mice, 3 publications between 2022 and 2024, average publication date March 2023. Dendrites, 2 publications between 2022 and 2024, average publication date May 2023. Pyramidal Cells, 2 publications between 2022 and 2024, average publication date May 2023. Receptors, N-Methyl-D-Aspartate, 2 publications between 2022 and 2024, average publication date May 2023. Synapses, 2 publications between 2022 and 2024, average publication date May 2023. Male, 1 publications between 2024 and 2024, average publication date August 2024. Mice, Inbred C57BL, 1 publications between 2024 and 2024, average publication date August 2024. Neuronal Plasticity, 1 publications between 2024 and 2024, average publication date August 2024.

To see the data from this visualization as text, click here.
Vardalaki's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.